If you have severe, end-stage, non-malignant pulmonary disease that can’t be treated with medication or breathing devices, a lung transplant can prolong and improve the quality of your life. Lung transplant patients often have diseases of the lung, including emphysema, cystic fibrosis, pulmonary fibrosis, and pulmonary hypertension.
Now approaching our 400th lung transplant operation, our Lung Disease and Transplantation Program is in the upper echelon of such programs in the country. We are ranked among the top in the nation for one-year post-transplant survival of lung transplant patients.
Our one- and three-year patient survival rates are better than any other program in North Texas. Our time to transplant is shorter than any other transplant center in North Texas. And the severity of illness – how ill our patients are – is the highest, but, despite that, our patients do better.
Much of our Program's success is due to the collaborative effort of our doctors who specialize in all aspects of cardiovascular care, including pulmonary, vascular, imaging, and transplantation medicine. Our multidisciplinary approach helps create and sustain excellence and enables the lung transplant program to excel in providing excellent care to each patient.
One of the many unique aspects of UT Southwestern’s lung transplant care is the Short-Term Support (STS) team.
When critically ill patients come to UT Southwestern, our STS team immediately initiates very aggressive life-support measures while they determine if the patient is a candidate for a lung transplant.
Among the measures deployed in such emergencies is a compact, portable heart-lung machine called CARDIOHELP, which is designed to provide extracorporeal support to replace or assist a patient’s circulation and respiration, helping physicians gain valuable time.
The STS team specializes in finding innovative ways to keep patients alive while they wait for a suitable donor.